TD Cowen Cuts Acadia Healthcare (NASDAQ:ACHC) Price Target to $66.00

Acadia Healthcare (NASDAQ:ACHC) had its price target reduced by TD Cowen from $70.00 to $66.00 in a research note published on Tuesday,Benzinga reports. They currently have a buy rating on the stock.

A number of other research analysts also recently commented on the company. Barclays reduced their target price on Acadia Healthcare from $76.00 to $43.00 and set an “overweight” rating on the stock in a report on Friday, November 22nd. Royal Bank of Canada decreased their price objective on shares of Acadia Healthcare from $94.00 to $64.00 and set an “outperform” rating for the company in a report on Monday, November 18th. Cantor Fitzgerald reissued a “neutral” rating and set a $52.00 target price on shares of Acadia Healthcare in a report on Tuesday, December 10th. Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price target for the company from $45.00 to $75.00 in a report on Thursday, December 12th. Finally, StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $70.22.

Acadia Healthcare Stock Up 0.6 %

ACHC stock opened at $45.13 on Tuesday. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. The firm has a 50 day simple moving average of $40.57 and a 200-day simple moving average of $58.37. The company has a market capitalization of $4.19 billion, a P/E ratio of 14.80, a PEG ratio of 1.77 and a beta of 1.29. Acadia Healthcare has a twelve month low of $36.50 and a twelve month high of $87.77.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.90 by $0.01. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. The company had revenue of $815.60 million during the quarter, compared to analyst estimates of $819.42 million. During the same period last year, the business earned $0.91 EPS. The firm’s revenue for the quarter was up 8.7% compared to the same quarter last year. On average, equities research analysts predict that Acadia Healthcare will post 3.38 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of the company. State Street Corp boosted its position in shares of Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock worth $178,811,000 after buying an additional 95,613 shares during the period. JPMorgan Chase & Co. raised its stake in Acadia Healthcare by 17.0% during the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after acquiring an additional 454,044 shares in the last quarter. LMR Partners LLP acquired a new position in Acadia Healthcare during the 3rd quarter worth $1,616,000. Principal Financial Group Inc. grew its stake in shares of Acadia Healthcare by 2.1% in the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock worth $41,653,000 after purchasing an additional 13,368 shares in the last quarter. Finally, Texas Permanent School Fund Corp increased its holdings in shares of Acadia Healthcare by 11.3% during the second quarter. Texas Permanent School Fund Corp now owns 89,821 shares of the company’s stock valued at $6,067,000 after purchasing an additional 9,115 shares during the period.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.